SeenewsSeenews
Search
Seenews
AlertsSeenewsSeenews
Searchclose
TOPICS
arrow
COUNTRIES
arrow
INDUSTRY
arrow
Economy
arrow
Browse Economy
Mix and match your focus countries with our advanced search
Investments
arrow
Browse Investments
Mix and match your focus countries with our advanced search
Deals
arrow
Browse Deals
Mix and match your focus countries with our advanced search
Tech
arrow
Browse Tech
Mix and match your focus countries with our advanced search
Green
arrow
Browse Green
Mix and match your focus countries with our advanced search
0/5
You have 5 free articles left this month
You have 0/5 free articles
Sign up to get 5 more free articles this month
SIGN UP
arrow
LOGIN
arrow

Bulgarian Rose plans 0.03 euro/share dividend for 2023

Mar 26, 2024, 4:16:35 PMArticle by Mihaela Miteva
share
March 26 (SeeNews) - Cosmetics producer Bulgarian Rose [BUL:ROZA] said on Tuesday that it is proposing to its shareholders to distribute a gross dividend of 0.05 levs ($0.028/0.026 euro) per share for 2023.

Bulgarian Rose plans 0.03 euro/share dividend for 2023
Photo: BGNES

The company plans to distribute a total of 267,549 levs in dividend for last year, including its net profit of 223,317 levs reported for 2023 and undistributed profit from previous years, Bulgarian Rose said in a bourse filing.

The proposal will be put to the vote at a general meeting of shareholders on May 16. If approved, the dividend will be disbursed over six months, starting July 8.

Bulgarian Rose paid out a gross dividend of 0.075 levs per share for 2022, or a total of 401,324 levs, according to previously disclosed information.

Karlovo-based Bulgarian Rose, established in 1948, manufactures cosmetic products for face, body, and hair using rose oil and locally-grown herbs. The company is part of local diversified group Stara Planina Hold [BUL:SPH].

As of 1505 CET on Tuesday, shares in Bulgarian Rose traded flat at 2.00 levs on the Bulgarian Stock Exchange.

(1 euro = 1.95583 levs)

Your complete guide to the emerging economies of Southeast Europe. From latest news to bespoke research – the big picture at the tip of your fingers.